Gf Fund Management Co. Ltd.

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-04-29
Total Holdings
666
Total Value
4262829836
Accession Number
0002057060-25-000003
Form Type
13F-HR
CIK
0002057060
Manager Name
Gf Fund Management Co. Ltd.
Data Enrichment
99% identified
658 identified8 unidentified

Holdings

666 positions
Manager:
SEC
Search and click to pin securities to the top
Page 29 of 34
590717401
590717401
Shares:
817(+21.8%)
Value:
$10.2M(-23.3%)
UNIVERSAL HEALTH REALTY INCOME TRUST
UHT|91359E105
Shares:
247(+4.2%)
Value:
$10.1M(+14.7%)
Oric Pharmaceuticals, Inc.
ORIC|68622P109
Shares:
1807(+21.9%)
Value:
$10.1M(-15.7%)
SIGA TECHNOLOGIES INC
SIGA|826917106
Shares:
1828(+21.9%)
Value:
$10.0M(+11.2%)
Tourmaline Bio, Inc.
TRML|89157D105
Shares:
656(+21.9%)
Value:
$10.0M(-8.6%)
Erasca, Inc.
ERAS|29479A108
Shares:
7240(+22.0%)
Value:
$9.9M(-33.4%)
Verve Therapeutics, Inc.
VERV|92539P101
Shares:
2167(+21.9%)
Value:
$9.9M(-1.2%)
Sana Biotechnology, Inc.
SANA|799566104
Shares:
5716(+21.9%)
Value:
$9.6M(+25.7%)
CorMedix Inc.
CRMD|21900C308
Shares:
1554(+22.0%)
Value:
$9.6M(-7.2%)
Community Healthcare Trust Inc
CHCT|20369C106
Shares:
527(+4.2%)
Value:
$9.6M(-1.5%)
Farmland Partners Inc.
FPI|31154R109
Shares:
858(+4.0%)
Value:
$9.6M(-1.4%)
BICYCLE THERAPEUTICS PLC
BCYC|088786108
Shares:
1126(+21.9%)
Value:
$9.6M(-26.1%)
EyePoint Pharmaceuticals, Inc.
EYPT|30233G209
Shares:
1747(+21.9%)
Value:
$9.5M(-11.3%)
Rapport Therapeutics, Inc.
RAPP|75383L102
Shares:
936(+21.9%)
Value:
$9.4M(-31.1%)
ALEXANDERS INC
ALX|014752109
Shares:
44(+7.3%)
Value:
$9.2M(+12.2%)
Oruka Therapeutics, Inc.
ORKA|687604108
Shares:
896(+21.9%)
Value:
$9.2M(-35.5%)
Altimmune, Inc.
ALT|02155H200
Shares:
1821(+22.0%)
Value:
$9.1M(-15.4%)
REGENXBIO Inc.
RGNX|75901B107
Shares:
1269(+22.0%)
Value:
$9.1M(+12.9%)
SAUL CENTERS, INC.
BFS|804395101
Shares:
250(+4.6%)
Value:
$9.0M(-2.7%)
Stoke Therapeutics, Inc.
STOK|86150R107
Shares:
1355(+21.9%)
Value:
$9.0M(-26.5%)